Odevixibat Scratches the Itch of Kids' Rare Liver Disease
(MedPage Today) -- Odevixibat (Bylvay) reduced intense itching and serum bile acids in children with progressive familial intrahepatic cholestasis (PFIC), as detailed in the publication of the PEDFIC 1 trial results that led to the drug's recent...
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news
More News: Bile | Children | Cholestasis | Dermatology | Itchiness | Liver | Liver Disease | Obstetric Cholestasis | Skin | Urology & Nephrology